Efficacy and Safety of Autologous Dendritic Cell–Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer

202287 citationsJournal Articlegreen Open Access

Authors

ClinicalTrials.gov Identifier: NCT02111577.

Good health and well-being

Published in: JAMA Oncology

Volume 8, Issue 4, pp. 546-546

Field-Weighted Citation Impact: 12.92